Back

Angiotensin-neprilysin inhibition in acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials

29 August 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (1) - Aggressive ways of saving patients Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Marah Hunjul

Nablus (Palestine, State of)

9 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor Y. Takei (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Doctor J. Ortega-Hernandez (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Doctor T. Inamori (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Professor I. Sabirov (Bishkek, KG)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (1) - Aggressive ways of saving patients

The Event

Event poster

ESC Congress 2025

29 August 2025 12:30 CET
You may be interested in
thumbnail
Congress Session
Neprilysin inhibition: news and nuggets
29 August 2022
thumbnail
Congress Presentation
Efficacy of early angiotensin receptor/neprilysin inhibition in post-myocardial infarction patients: a meta-analysis of randomized controlled trials
30 August 2025
thumbnail
Congress Presentation
Efficacy and safety of SGLT2 inhibitors in acute heart failure: a systematic review and meta-analysis of randomized controlled trials
19 May 2025
thumbnail
Congress Presentation
Efficacy of ARNI in patients using LVAD: a systematic review and meta-analysis
13 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources